NCCT Markers of Intracerebral Hemorrhage Expansion Using Revised Criteria: An External Validation of Their Predictive Accuracy

References

1. 1.↵
   GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20:795–820 doi:10.1016/S1474-4422(21)00252-0 pmid:34487721

   CrossRefPubMed
2. 2.↵
   1. Dowlatshahi D,
   2. Demchuk AM,
   3. Flaherty ML, et al

   ; VISTA Collaboration. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology 2011;76:1238–44 doi:10.1212/WNL.0b013e3182143317 pmid:21346218

   Abstract/FREE Full Text
3. 3.↵
   1. Demchuk AM,
   2. Dowlatshahi D,
   3. Rodriguez-Luna D, et al

   ; PREDICT/Sunnybrook ICH CTA Study Group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012;11:307–14 doi:10.1016/S1474-4422(12)70038-8 pmid:22405630

   CrossRefPubMed
4. 4.↵
   1. Morotti A,
   2. Boulouis G,
   3. Dowlatshahi D, et al

   ; International NCCT ICH Study Group. Standards for detecting, interpreting, and reporting noncontrast computed tomographic markers of intracerebral hemorrhage expansion. Ann Neurol 2019;86:480–92 doi:10.1002/ana.25563 pmid:31364773

   CrossRefPubMed
5. 5.↵
   1. Yogendrakumar V,
   2. Ramsay T,
   3. Fergusson DA, et al

   ; PREDICT/Sunnybrook CTA Study Group. Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth. Stroke 2020;51:1120–27 doi:10.1161/STROKEAHA.119.027451 pmid:32078498

   CrossRefPubMed
6. 6.↵
   1. Yogendrakumar V,
   2. Ramsay T,
   3. Fergusson D, et al

   ; the PREDICT/Sunnybrook CTA Study Group. New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhage. Neurology 2019;93:e879–88 doi:10.1212/WNL.0000000000008007 pmid:31371565

   Abstract/FREE Full Text
7. 7.↵
   1. Yang WS,
   2. Zhang SQ,
   3. Shen YQ, et al

   . Noncontrast computed tomography markers as predictors of revised hematoma expansion in acute intracerebral hemorrhage. J Am Heart Assoc 2021;10:e018248 doi:10.1161/JAHA.120.018248 pmid:33506695

   CrossRefPubMed
8. 8.↵
   1. Al-Shahi Salman R,
   2. Frantzias J,
   3. Lee RJ, et al

   ; ICH Growth Individual Patient Data Meta-analysis Collaborators. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol 2018;17:885–94 doi:10.1016/S1474-4422(18)30253-9 pmid:30120039

   CrossRefPubMed
9. 9.↵
   1. Morotti A,
   2. Brouwers HB,
   3. Romero JM, et al

   ; Antihypertensive Treatment of Acute Cerebral Hemorrhage II and Neurological Emergencies Treatment Trials Investigators. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol 2017;74:950–60 doi:10.1001/jamaneurol.2017.1014 pmid:28628707

   CrossRefPubMed
10. 10.↵
    1. Gladstone DJ,
    2. Aviv RI,
    3. Demchuk AM, et al

    ; SPOTLIGHT and STOP-IT Investigators and Coordinators. Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT Randomized Clinical Trials. JAMA Neurol 2019;76:1493–501 doi:10.1001/jamaneurol.2019.2636 pmid:31424491

    CrossRefPubMed
11. 11.↵
    1. Morotti A,
    2. Arba F,
    3. Boulouis G, et al

    . Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome: a meta-analysis. Neurology 2020;95:632–43 doi:10.1212/WNL.0000000000010660 pmid:32847959

    Abstract/FREE Full Text
12. 12.↵
    1. Parry-Jones AR,
    2. Sammut-Powell C,
    3. Paroutoglou K, et al

    . An intracerebral hemorrhage care bundle is associated with lower case fatality. Ann Neurol 2019;86:495–503 doi:10.1002/ana.25546 pmid:31291031

    CrossRefPubMed
13. 13.↵
    1. Song L,
    2. Hu X,
    3. Ma L, et al

    ; INTERACT3 Investigators. INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial. Trials 2021;22:943 doi:10.1186/s13063-021-05881-7 pmid:34930428

    CrossRefPubMed
14. 14.↵
    1. Morotti A,
    2. Boulouis G,
    3. Charidimou A, et al

    . Hematoma expansion in intracerebral hemorrhage with unclear onset. Neurology 2021;96:e2363–71 doi:10.1212/WNL.0000000000011895 pmid:33795389

    Abstract/FREE Full Text
15. 15.↵
    1. Francesco A,
    2. Chiara R,
    3. Gregoire B, et al

    . Noncontrast computed tomography markers of cerebral hemorrhage expansion: diagnostic accuracy meta-analysis. Int J Stroke 2021 Nov 29. [Epub ahead of print] doi:10.1177/17474930211061639 pmid:34842473

    CrossRefPubMed
16. 16.↵
    1. Dowlatshahi D,
    2. Morotti A,
    3. Al-Ajlan FS, et al

    . Interrater and intrarater measurement reliability of noncontrast computed tomography predictors of intracerebral hemorrhage expansion. Stroke 2019;50:1260–62 doi:10.1161/STROKEAHA.118.024050 pmid:30909839

    CrossRefPubMed
17. 17.↵
    1. Bossuyt PM,
    2. Reitsma JB,
    3. Bruns DE, et al

    ; STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527 doi:10.1136/bmj.h5527 pmid:26511519

    FREE Full Text
18. 18.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M, et al

    ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495–99 doi:10.1016/j.ijsu.2014.07.013 pmid:25046131

    CrossRefPubMed
19. 19.↵
    1. Li Q,
    2. Shen YQ,
    3. Xie XF, et al

    . Expansion-prone hematoma: defining a population at high risk of hematoma growth and poor outcome. Neurocrit Care 2019;30:601–08 doi:10.1007/s12028-018-0644-3 pmid:30430380

    CrossRefPubMed
20. 20.↵
    1. Cook NR

    . Quantifying the added value of new biomarkers: how and how not. Diagn Progn Res 2018;2:14 doi:10.1186/s41512-018-0037-2 pmid:31093563

    CrossRefPubMed
21. 21.↵
    1. Law ZK,
    2. Ali A,
    3. Krishnan K, et al

    ; TICH-2 Investigators. Noncontrast computed tomography signs as predictors of hematoma expansion, clinical outcome, and response to tranexamic acid in acute intracerebral hemorrhage. Stroke 2020;51:121–28 doi:10.1161/STROKEAHA.119.026128 pmid:31735141

    CrossRefPubMed
22. 22.↵
    1. Zimmer S,
    2. Meier J,
    3. Minnerup J, et al

    . Prognostic value of non-contrast CT markers and spot sign for outcome prediction in patients with intracerebral hemorrhage under oral anticoagulation. J Clin Med 2020;9:1077 doi:10.3390/jcm9041077 pmid:32290209

    CrossRefPubMed
23. 23.↵
    1. He GN,
    2. Guo HZ,
    3. Han X, et al

    . Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH. J Neurol 2018;265:1883–90 doi:10.1007/s00415-018-8932-6 pmid:29948249

    CrossRefPubMed
24. 24.↵
    1. Katsanos AH,
    2. Gupta H,
    3. Morotti A, et al

    . Increased prognostic yield by combined assessment of non-contrast computed tomography markers of antithrombotic-related spontaneous intracerebral hemorrhage expansion. J Clin Med 2022;11:1596 doi:10.3390/jcm11061596 pmid:35329922

    CrossRefPubMed
25. 25.↵
    1. Morotti A,
    2. Boulouis G,
    3. Romero JM, et al

    ; ATACH-II and NETT investigators. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology 2017;89:548–54 doi:10.1212/WNL.0000000000004210 pmid:28701501

    Abstract/FREE Full Text
26. 26.↵
    1. Yu Z,
    2. Zheng J,
    3. He M, et al

    . Accuracy of swirl sign for predicting hematoma enlargement in intracerebral hemorrhage: a meta-analysis. J Neurol Sci 2019;399:155–60 doi:10.1016/j.jns.2019.02.032 pmid:30818076

    CrossRefPubMed
27. 27.↵
    1. Nehme A,
    2. Ducroux C,
    3. Panzini MA, et al

    . Non-contrast CT markers of intracerebral hematoma expansion: a reliability study. Eur Radiol 2022;32:6126–35 doi:10.1007/s00330-022-08710-w pmid:35348859

    CrossRefPubMed
28. 28.↵
    1. Li H,
    2. Xie Y,
    3. Liu H, et al

    . Non-contrast CT-based radiomics score for predicting hematoma enlargement in spontaneous intracerebral hemorrhage. Clin Neuroradiol 2022;32:517–28 doi:10.1007/s00062-021-01062-w pmid:34324004

    CrossRefPubMed
29. 29.↵
    1. Boulouis G,
    2. Dumas A,
    3. Betensky RA, et al

    . Anatomic pattern of intracerebral hemorrhage expansion: relation to CT angiography spot sign and hematoma center. Stroke 2014;45:1154–56 doi:10.1161/STROKEAHA.114.004844 pmid:24603066

    Abstract/FREE Full Text
30. 30.↵
    1. Dowlatshahi D,
    2. Brouwers HB,
    3. Demchuk AM, et al

    . Predicting intracerebral hemorrhage growth with the spot sign: the effect of onset-to-scan time. Stroke 2016;47:695–700 doi:10.1161/STROKEAHA.115.012012 pmid:26846857

    Abstract/FREE Full Text
31. 31.↵
    1. Qureshi AI,
    2. Palesch YY,
    3. Barsan WG, et al

    ; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016;375:1033–43 doi:10.1056/NEJMoa1603460 pmid:27276234

    CrossRefPubMed
32. 32.↵
    1. Anderson CS,
    2. Heeley E,
    3. Huang Y, et al

    ; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355–65 doi:10.1056/NEJMoa1214609 pmid:23713578

    CrossRefPubMedWeb of Science